Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline APOBEC3B deletion: results of the phase II AUROR study
帕博利珠单抗单药治疗既往接受过治疗且携带种系APOBEC3B缺失的转移性HER2阴性乳腺癌:II期AUROR研究结果
期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2025.101637
Ho, Gwo Fuang; Lee, Soo Chin; Bustam, Anita Zarina; Alip, Adlinda; Abdul Satar, Nur Fadhlina; Saad, Marniza; Malik, Rozita Abdul; Lim, Siew Eng; Ow, Samuel G W; Wong, Andrea; Chong, Wan-Qin; Ang, Yvonne L E; Lee, Audrey Weng Yan; Hasan, Siti Norhidayu; Tuan Zaid, Nabilah; Law, Kian Boon; Toh, Yok Yong; Tan, Hooi Chiao; Selvam, Bawani; Lim, Joanna; Pan, Jia-Wern; Teo, Soo Hwang